Pharma & Healthcare
ELSI was created thanks to the complementary expertise and experience of its partners, who place the marketing and distribution strategy at the heart of its DNA, in order to offer its clients multidisciplinary, transparent and pragmatic support.Let's meet
Thanks to the experience of its partners, in pharmaceutical companies, health authorities and law firms, ELSI was created with the will to offer a different approach, breaking with the empirical codes of existing practices:
Agile & accessible lawyers
A pragmatic, simple & transparent approach
ELSI's approach is to work for its clients in a simple and transparent manner. This is why we have created and implemented tailor-made regulatory consulting subscriptions:
Regulatory advice subscription
Anti-gift & transparency outsourcing
ELSI continues to mobilise in this difficult period to bring you its support and expertise acquired in the field of health products used in the context of the COVID-19 health crisis.
Whether it is a question of diagnostic tests - reagents, vaccines, masks, oxygen, software or any other health product, or the setting up of research and clinical investigations, our team remains at your disposal to accompany you in the marketing and distribution strategy.
Legal and regulatory updates, skills upgrading, find out about all our customised training offers adapted to your needs.+
Our outsourcing offer, the subcontracting of your anti-gift activities & health transparency+
Subscription to regulatory advice, audit packages, find all our subscription and subcontracting offers.
Transformation, temporary surge, implementation of new processes or crisis management, the ELSI team will support you.
Find our latest news and communications
An investigation by the DGCCRF in 2021 led to the penalization of 6.6 million euros for illegal practices by the URGO group.
Medical device law
An amendment to the WDR has just been proposed by the European Commission to postpone the entry into force of the WDR.